Tretinoin, the active form of vitamin A used in acne and anti-aging treatments, is built from surprisingly simple raw materials through a series of chemical reactions that assemble its 20-carbon molecular chain. The process starts with basic industrial chemicals, moves through carefully controlled synthesis steps, and ends with the pure powder being formulated into the creams and gels you find at the pharmacy.
The Raw Materials
Tretinoin’s molecular backbone contains 20 carbon atoms, and most of them come from just two starting chemicals: acetone and acetylene. In the well-established Roche synthesis route (developed by the Swiss pharmaceutical company Hoffman-La Roche), 12 of the 20 carbon atoms come from acetone and 6 from acetylene. The remaining two carbons are supplied by formaldehyde and one other small reagent. These are all commodity chemicals produced on an enormous industrial scale, which is part of what makes large-volume vitamin A and tretinoin production economically viable.
Other raw materials that feed into various production routes include acetic acid, methanol, and methyl vinyl ketone. Several of these starting chemicals can now be sourced from renewable feedstocks rather than petroleum, though the final molecule is identical regardless of the source.
Building the Carbon Skeleton
The central challenge in making tretinoin is constructing its long, conjugated side chain, a string of alternating single and double bonds attached to a six-membered ring. Manufacturers build this structure in stages, assembling smaller carbon fragments into progressively larger ones.
The most important intermediate along the way is beta-ionone, a violet-scented compound that forms the ring portion of the molecule along with part of the side chain. Two main routes exist for making beta-ionone: one builds it stepwise from acetone and acetylene, while the other starts from synthetic citral (a lemon-scented compound). DSM-Firmenich, one of the world’s largest vitamin A producers, uses the acetone-and-acetylene route.
Once the ring fragment is in hand, it needs to be joined to additional carbon units to reach the full 20-carbon chain. This is where the key bond-forming reactions come in. The Wittig reaction is the workhorse of modern tretinoin and vitamin A synthesis. It joins two molecular fragments by creating a new carbon-carbon double bond between them, and it does so with good control over the geometry of that bond. Getting the geometry right matters enormously: tretinoin is specifically the “all-trans” form of retinoic acid, meaning every double bond in its side chain has a particular spatial arrangement. The wrong geometry produces isotretinoin (the active ingredient in Accutane) or other less useful isomers instead.
BASF, another major producer, uses a variation of this approach. Their route employs a Wittig reaction to attach a five-carbon aldehyde fragment, which they prepare from butynediol (itself made from acetylene and formaldehyde using copper-based catalysts). An alternative path to that same fragment starts from a mixture of butadiene and butene, reacted with acetic acid under high pressure in the presence of a palladium catalyst.
From Vitamin A to Tretinoin
Most industrial tretinoin production is closely linked to vitamin A (retinol) manufacturing, since the two molecules are nearly identical. Retinol has an alcohol group at the end of its chain; tretinoin has a carboxylic acid group in the same position. Converting one to the other requires an oxidation step that transforms the alcohol into an acid, typically carried out with well-established chemical oxidants. This means the massive global infrastructure for vitamin A production, originally built for animal feed and food fortification, also supplies the pharmaceutical market with tretinoin.
Why Light and Air Are the Enemy
Tretinoin degrades rapidly when exposed to light. That same chain of alternating double bonds that gives the molecule its biological activity also makes it highly reactive with ultraviolet and even fluorescent light. During manufacturing, this means the synthesis, purification, and packaging steps all require carefully controlled lighting conditions. Workers use amber or red-filtered lighting, and the compound is stored in opaque containers under inert gas to prevent both light degradation and oxidation from air exposure.
Temperature control matters too. The compound is handled and stored at cool temperatures to slow any unwanted chemical breakdown. Dust formation is minimized through enclosed processing systems and local exhaust ventilation, because the raw powder is a reproductive hazard that workers must not inhale or absorb through skin. Full protective equipment, including respirators with dust filters, chemical-resistant gloves, and safety glasses, is required at every stage of handling.
Purity Standards for Pharmaceutical Grade
Before tretinoin powder can go into any prescription product, it must meet strict pharmacopeial standards. The United States Pharmacopeia requires that pharmaceutical-grade tretinoin contain between 97.0% and 103.0% pure tretinoin on a dried basis. The most closely watched impurity is isotretinoin, the 13-cis isomer, which must stay below 5.0% of the total content. Residual moisture must be no more than 0.5%, and non-volatile residues (leftover inorganic material) must be below 0.1%.
Identity is confirmed through ultraviolet absorption testing, which exploits the fact that tretinoin absorbs light at characteristic wavelengths due to its conjugated double-bond system. The readings from a test sample must match reference standards within 3.0%. These tests collectively ensure that every batch of raw tretinoin performs consistently when formulated into finished products.
Turning Powder Into Products
Once the pure tretinoin powder passes quality testing, it gets incorporated into the topical creams, gels, and lotions that patients actually use. This formulation step is its own engineering challenge, because tretinoin is lipophilic (fat-soluble) and doesn’t dissolve easily in water-based vehicles.
Conventional cream formulations use oil-in-water emulsions, where tretinoin dissolves in the oil phase and is then dispersed into tiny droplets within a water-based cream. Gel formulations typically use an alcohol or aqueous base with solubilizing agents to keep the tretinoin evenly distributed. The choice of vehicle affects how the drug penetrates skin, how stable it remains in the tube, and how much irritation it causes.
Newer formulation technologies have pushed the boundaries further. Microsphere formulations encapsulate tretinoin inside tiny polymer spheres that protect it from light and oxygen degradation, then release the drug gradually after application. Nanogel formulations use oil droplets smaller than 0.2 microns to dissolve the tretinoin, improving its penetration into hair follicles and oil glands while using a water-based gel vehicle that feels lighter and more moisturizing on the skin. These delivery systems address the two oldest complaints about tretinoin products: instability in light and skin irritation from concentrated surface exposure.